AlphaMissense 리뷰

REVEL is an ensemble method that integrates scores from 13 individual prediction tools to provide a comprehensive pathogenicity score for rare missense variants.

Unlike AlphaMissense's deep learning model based on protein sequences and structural context, REVEL combines multiple existing predictors. Both aim to classify missense variants, but REVEL focuses on rare variants and provides a score from 0 to 1, with higher scores indicating greater likelihood of being disease-causing.

CADD provides a single, genome-wide deleteriousness score for all types of variants (SNVs and indels), integrating over 60 diverse genomic features.

While AlphaMissense specifically targets missense variants using deep learning, CADD offers broader applicability across all variant types, providing a PHRED-like score that ranks deleteriousness rather than a direct pathogenic/benign classification.

PathoPredictor is an interpretable machine-learning framework designed to distinguish pathogenic from benign missense variants using curated clinical variant data and functional annotations.

Similar to AlphaMissense, PathoPredictor uses machine learning for missense variant classification, but it emphasizes interpretability and is trained on curated clinical data, whereas AlphaMissense leverages protein sequences and structural context from AlphaFold methodology.

PrimateAI-3D quantifies missense variant pathogenicity using a deep-learning network trained on genetic variants from 233 primate species, leveraging evolutionary conservation across primates.

Both AlphaMissense and PrimateAI-3D utilize deep learning and evolutionary data for missense variant prediction. PrimateAI-3D specifically focuses on primate genetic variants for training, while AlphaMissense builds on the AlphaFold methodology and uses databases of related protein sequences and structural context.